Eli Lilly buys new injectable medicine manufacturing facility from Nexus Pharma Ruchika Sharma23 April 2024 12:30 PM ISTIndianapolis: Eli Lilly and Company and Nexus Pharmaceuticals, LLC have announced a definitive agreement for Lilly to acquire a manufacturing...
Roche gets USFDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis Ruchika Sharma11 April 2024 5:47 PM ISTBasel: Roche has announced that its Elecsys pTau217 assay has received Breakthrough Device Designation from the U.S. Food and Drug Administration...
Eli Lilly Gets CDSCO Panel Nod To Import, Market Anti-cancer Drug Selpercatinib Dr. Divya Colin9 April 2024 6:00 PM ISTNew Delhi: Advising to conduct the Phase IV clinical trial, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Strides Pharma Science Singapore arm gets USFDA nod for Major Depressive Disorder drug Fluoxetine Ruchika Sharma9 April 2024 12:30 PM ISTThe product is bioequivalent and therapeutically equivalent to the Reference Listed Drug Prozac Tablets of Eli Lilly.
Eli Lilly Gets CDSCO Panel Nod To Market Mirikizumab for ulcerative colitis in adults Dr. Divya Colin7 April 2024 6:00 PM ISTNew Delhi: Pharmaceutical major Eli Lilly has got marketing authorization from the Subject Expert Committee (SEC) functional under the Central Drug...
Lebrikizumab demonstrates efficacy in atopic dermatitis and skin of color patients in first of its kind study Dr. Kamal Kant Kohli11 March 2024 2:30 AM ISTAtopic dermatitis (AD) is a chronic inflammatory skin disorder with limited treatment options for adolescents with moderate-to-severe disease. ...
USFDA delays decision on Eli Lilly Alzheimer's drug Donanemab Ruchika Sharma10 March 2024 4:30 PM ISTWhite said the FDA wants the expert panel to discuss some of the unique aspects of the clinical trial used in its request for a traditional FDA...
Eli Lilly finds bacteria, other impurities in Mounjaro, Zepbound knockoffs Ruchika Sharma8 March 2024 5:48 PM ISTEli Lilly said on Thursday it has found bacteria and high levels of impurities in products claiming to be compounded versions of tirzepatide, the...
Eli Lilly expects to launch diabetes drug Mounjaro in India next year: CEO Ruchika Sharma29 Feb 2024 12:30 PM ISTMounjaro, chemically known as tirzepatide, is currently sold in the UK and Europe under the same brand name for both conditions.
EU drug regulator to review use of Eli Lilly Mounjaro in multi-dose pen Ruchika Sharma20 Feb 2024 1:30 PM ISTFrankfurt: The European Union's healthcare regulator will this week review the use of Eli Lilly's approved Mounjaro drug against diabetes and...
Fractyl Health targets up to $762 mln valuation in US IPO Kajal Rajput30 Jan 2024 3:45 PM ISTBengaluru: Obesity and diabetes drug developer Fractyl Health said on Monday it was aiming for a market valuation of up to $762 million in its U.S....
Johna Norton to retire as Eli Lilly Executive Vice President of Global Quality Ruchika Sharma28 Jan 2024 4:00 PM ISTIndianapolis: Eli Lilly and Company has announced that Johna Norton, executive vice president of Global Quality, will be retiring after...
